Addictive potential of cannabinoids: the underlying neurobiology

Addictive potential of cannabinoids: the underlying neurobiology Drugs that are addictive in humans have a number of commonalities in animal model systems—(1) they enhance electrical brain-stimulation reward in the core meso-accumbens reward circuitry of the brain, a circuit encompassing that portion of the medial forebrain bundle (MFB) which links the ventral tegmental area (VTA) of the mesencephalic midbrain with the nucleus accumbens (Acb) of the ventral limbic forebrain; (2) they enhance neural firing of a core dopamine (DA) component of this meso-accumbens reward circuit; (3) they enhance DA tone in this reward-relevant meso-accumbens DA circuit, with resultant enhancement of extracellular Acb DA; (4) they produce conditioned place preference (CPP), a behavioral model of incentive motivation; (5) they are self-administered; and (6) they trigger reinstatement of drug-seeking behavior in animals behaviorally extinguished from intravenous drug self-administration behavior and, perforce, pharmacologically detoxified from their self-administered drug. Cannabinoids were long considered ‘anomalous’, in that they were believed to not interact with these brain reward processes or support drug-seeking and drug-taking behavior in these animal model systems. However, it is now clear—from the published data of several research groups over the last 15 years—that this view of cannabinoid action on brain reward processes and reward-related behaviors is untenable. This paper reviews those data, and concludes that cannabinoids act on brain reward processes and reward-related behaviors in strikingly similar fashion to other addictive drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Chemistry and Physics of Lipids Elsevier

Addictive potential of cannabinoids: the underlying neurobiology

Chemistry and Physics of Lipids, Volume 121 (1) – Dec 31, 2002

Loading next page...
 
/lp/elsevier/addictive-potential-of-cannabinoids-the-underlying-neurobiology-NuMYVaUZI0
Publisher
Elsevier
Copyright
Copyright © 2002 Elsevier Science Ireland Ltd
ISSN
0009-3084
eISSN
1873-2941
D.O.I.
10.1016/S0009-3084(02)00162-7
Publisher site
See Article on Publisher Site

Abstract

Drugs that are addictive in humans have a number of commonalities in animal model systems—(1) they enhance electrical brain-stimulation reward in the core meso-accumbens reward circuitry of the brain, a circuit encompassing that portion of the medial forebrain bundle (MFB) which links the ventral tegmental area (VTA) of the mesencephalic midbrain with the nucleus accumbens (Acb) of the ventral limbic forebrain; (2) they enhance neural firing of a core dopamine (DA) component of this meso-accumbens reward circuit; (3) they enhance DA tone in this reward-relevant meso-accumbens DA circuit, with resultant enhancement of extracellular Acb DA; (4) they produce conditioned place preference (CPP), a behavioral model of incentive motivation; (5) they are self-administered; and (6) they trigger reinstatement of drug-seeking behavior in animals behaviorally extinguished from intravenous drug self-administration behavior and, perforce, pharmacologically detoxified from their self-administered drug. Cannabinoids were long considered ‘anomalous’, in that they were believed to not interact with these brain reward processes or support drug-seeking and drug-taking behavior in these animal model systems. However, it is now clear—from the published data of several research groups over the last 15 years—that this view of cannabinoid action on brain reward processes and reward-related behaviors is untenable. This paper reviews those data, and concludes that cannabinoids act on brain reward processes and reward-related behaviors in strikingly similar fashion to other addictive drugs.

Journal

Chemistry and Physics of LipidsElsevier

Published: Dec 31, 2002

References

  • What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience
    Berridge, K.C.; Robinson, T.E.
  • Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
    Braida, D.; Pozzi, M.; Parolaro, D.; Sala, M.
  • Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation
    Corcoran, M.E.; Amit, Z.
  • Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders
    Crowley, T.J.; Macdonald, M.J.; Whitmore, E.A.; Mikulich, S.K.
  • Reinstatement of cocaine-reinforced responding in the rat
    de Wit, H.; Stewart, J.
  • Drug reinstatement of heroin-reinforced responding in the rat
    de Wit, H.; Stewart, J.
  • Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
    Diana, M.; Melis, M.; Gessa, G.L.
  • Cannabinoid receptors and their endogenous agonists
    Felder, C.C.; Glass, M.
  • Amygdala and the memory of reward
    Gaffan, D.
  • What we have learned about addiction from animal models of drug self-administration
    Gardner, E.L.
  • Cannabinoid transmission and reward-related events
    Gardner, E.L.; Vorel, S.R.
  • Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain
    Gessa, G.L.; Diana, M.
  • Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB 1 receptors
    Gessa, G.L.; Melis, M.; Muntoni, A.L.; Diana, M.
  • Lithium chloride and delta-9-THC lead to conditioned aversions in the pigeon
    Goett, J.M.; Kay, E.J.
  • Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and in their regulation by chronic morphine
    Guitart, X.; Beitner-Johnson, D.; Nestler, E.J.
  • Reward shifts and motor responses following microinjections of opiate-specific agonists into either the core or shell of the nucleus accumbens
    Johnson, P.I.; Goodman, J.B.; Condon, R.; Stellar, J.R.
  • Aversion instead of preference learning indicated by nicotine place conditioning in rats
    Jorenby, D.E.; Steinpreis, R.E.; Sherman, J.E.; Baker, T.B.
  • Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains
    Kosten, T.A.; Miserendino, M.J.; Haile, C.N.; DeCaprio, J.L.; Jatlow, P.I.; Nestler, E.J.
  • The reverse transport of DA, what physiological significance?
    Leviel, V.
  • Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies
    McBride, W.J.; Murphy, J.M.; Ikemoto, S.
  • Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli
    McFarland, K.; Ettenberg, A.
  • Aversive effects of the synthetic cannabinoid CP 55,940 in rats
    McGregor, I.S.; Issakidis, C.N.; Prior, G.
  • Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine
    Parsons, L.H.; Smith, A.D.; Justice, J.B.
  • Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy
    Richardson, N.R.; Roberts, D.C.S.
  • Endogenous cannabinoids as an aversive or counter-rewarding system in the rat
    Sañudo-Peña, M.C.; Tsou, K.; Delay, E.R.; Hohman, A.G.; Force, M.; Walker, J.M.
  • Molecular mechanisms of drug reinforcement and addiction
    Self, D.W.; Nestler, E.J.
  • Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal
    Shaham, Y.; Stewart, J.
  • Neural basis of utility estimation
    Shizgal, P.
  • Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum
    Tzavara, E.T.; Valjent, E.; Firmo, C.; Mas, M.; Beslot, F.; Defer, N.; Roques, B.P.; Hanoune, J.; Maldonado, R.
  • Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues
    Tzschentke, T.M.
  • Addictive drugs and brain stimulation reward
    Wise, R.A.
  • Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds
    Wise, R.A.; Munn, E.
  • Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats
    Wise, R.A.; Murray, A.; Bozarth, M.A.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off